# Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Source: https://onco.cc/trials/nct07098598/  
OnCo record `nct07098598` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in pancreatic cancer, run by Turku University Hospital, now recruiting.

## Summary

Pancreatic Cancer Diagnosis With FAPI-PET Imaging is a phase 2/3, interventional study registered as NCT07098598 by Turku University Hospital, with a registry enrolment figure of 100 participants, started 2024-10-09 and due to reach its primary completion in 2026-10. Interventions recorded: PET/CT. Conditions listed: Positron Emission Tomography; Pancreatic Cancer; FAPI; Diagnostics; Recurrent Pancreatic Cancer; Oncologic Surgery; Imaging, Diagnostic; Staging. Primary outcome: 1) To assess the sensitivity and specificity of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer; 2) To assess the sensitivity and specificity 18F-FAPI-74 PET/CT in detection of distant metastasis in patient level in patients . Pancreatic eligibility wording from the registry: "* Suspected primary or recurrent pancreatic cancer". Sites: Finland. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07098598
- Phase: 2/3
- Setting: Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients With Pancreatic Cancer
- Sponsor: Turku University Hospital
- Enrolled: 100

## Sources

- ClinicalTrials.gov NCT07098598: https://clinicaltrials.gov/study/NCT07098598

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07098598.json